Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

A novel SCARB2 mutation in progressive myoclonus epilepsy indicated by reduced β-glucocerebrosidase activity.

Zeigler M, Meiner V, Newman JP, Steiner-Birmanns B, Bargal R, Sury V, Mengistu G, Kakhlon O, Leykin I, Argov Z, Abramsky O, Lossos A.

J Neurol Sci. 2014 Apr 15;339(1-2):210-3. doi: 10.1016/j.jns.2014.01.022. Epub 2014 Jan 23.

PMID:
24485911
2.

A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand binding.

Iavarone C, Ramsauer K, Kubarenko AV, Debasitis JC, Leykin I, Weber AN, Siggs OM, Beutler B, Zhang P, Otten G, D'Oro U, Valiante NM, Mbow ML, Visintin A.

J Immunol. 2011 Apr 1;186(7):4213-22. doi: 10.4049/jimmunol.1003585. Epub 2011 Mar 7.

3.

Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD mice.

Nikolic B, Onoe T, Takeuchi Y, Khalpey Z, Primo V, Leykin I, Smith RN, Sykes M.

Transplantation. 2010 Jan 15;89(1):23-32. doi: 10.1097/TP.0b013e3181c4692e.

4.

Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice.

Katic M, Kennedy AR, Leykin I, Norris A, McGettrick A, Gesta S, Russell SJ, Bluher M, Maratos-Flier E, Kahn CR.

Aging Cell. 2007 Dec;6(6):827-39.

5.
6.

Comparative linkage analysis and visualization of high-density oligonucleotide SNP array data.

Leykin I, Hao K, Cheng J, Meyer N, Pollak MR, Smith RJ, Wong WH, Rosenow C, Li C.

BMC Genet. 2005 Feb 15;6:7.

7.

Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity.

Nikolic B, Takeuchi Y, Leykin I, Fudaba Y, Smith RN, Sykes M.

Diabetes. 2004 Feb;53(2):376-83.

8.

Chemical genetic modifier screens: small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation.

Koeller KM, Haggarty SJ, Perkins BD, Leykin I, Wong JC, Kao MC, Schreiber SL.

Chem Biol. 2003 May;10(5):397-410.

9.

Extensive and divergent circadian gene expression in liver and heart.

Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH, Weitz CJ.

Nature. 2002 May 2;417(6884):78-83. Epub 2002 Apr 21. Erratum in: Nature 2002 Aug 8;418(6898):665.

PMID:
11967526
10.

Mixed bone marrow chimerism as a treatment for autoimmune diabetes.

Leykin I, Nikolic B, Sykes M.

Transplant Proc. 2001 Feb-Mar;33(1-2):120. No abstract available.

PMID:
11266737
11.

Detection of platelet-bound antibodies in beagle dogs after artificial infection with Ehrlichia canis.

Waner T, Leykin I, Shinitsky M, Sharabani E, Buch H, Keysary A, Bark H, Harrus S.

Vet Immunol Immunopathol. 2000 Nov 23;77(1-2):145-50.

PMID:
11068072
12.

Elevated cellular immune response to human heat-shock protein-60 in schizophrenic patients.

Leykin I, Spivak B, Weizman A, Cohen IR, Shinitzky M.

Eur Arch Psychiatry Clin Neurosci. 1999;249(5):238-46.

PMID:
10591989
13.

Evaluation of immune memory of human lymphocytes engrafted in SCID mice.

Peled A, Leykin I, Deckmann M, Shinitzky M.

Immunobiology. 1999 Sep;201(1):145-50.

PMID:
10532287
14.

Short and long-term immunosuppressive effects of clozapine and haloperidol.

Leykin I, Mayer R, Shinitzky M.

Immunopharmacology. 1997 Aug;37(1):75-86.

PMID:
9285246
15.

Side effect profile of azathioprine in the treatment of chronic schizophrenic patients.

Levine J, Gutman J, Feraro R, Levy P, Kimhi R, Leykin I, Deckmann M, Handzel ZT, Shinitzky M.

Neuropsychobiology. 1997;36(4):172-6.

PMID:
9396015
16.

Treatment of schizophrenia with an immunosuppressant.

Levine J, Susnovski M, Handzel ZT, Leykin I, Shinitzky M.

Lancet. 1994 Jul 2;344(8914):59-60. No abstract available. Erratum in: Lancet 1994 Jul 30;344(8918):346.

PMID:
7912324
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk